Patrick Soon-Shiong: Surgeon, Inventor of Abraxane and Owner of the LA Times

Patrick Soon-Shiong: Surgeon, Inventor of Abraxane and Owner of the LA Times

Business Owner · Biotechnology

Los Angeles

Patrick Soon-Shiong invented the cancer drug Abraxane, founded the healthcare network NantWorks, and has owned the Los Angeles Times since 2018.

About Patrick Soon-Shiong: Surgeon, Inventor of Abraxane and Owner of the LA Times

Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, researcher and surgeon who invented Abraxane, a drug used for lung, breast and pancreatic cancer. He has been the owner and executive chairman of the Los Angeles Times since 2018. In 2024 he received FDA approval for a new class of immunotherapy drug, Anktiva, in non-muscle invasive bladder cancer. He founded NantWorks, a network of healthcare, biotech and artificial intelligence startups, is an adjunct professor of surgery and executive director of the Wireless Health Institute at UCLA, a visiting professor at Imperial College London and Dartmouth College, and executive chairman and global chief medical and technology officer at ImmunityBio. He has been a minority owner of the Los Angeles Lakers since 2010, chairs the Chan Soon-Shiong Family Foundation, and his net worth is estimated at US$16.6 billion as of 2026 by Bloomberg and Forbes; he has been called the richest man in Los Angeles and one of the wealthiest doctors in the world. Soon-Shiong was born in Port Elizabeth, then part of the Union of South Africa, to Chinese immigrant parents of Hakka descent from Meixian District in Guangdong who fled China during the Japanese occupation in World War II. He graduated from the University of Witwatersrand, ranked fourth in his class of 189, with a Bachelor of Medicine. Sources: English Wikipedia (Patrick Soon-Shiong, accessed September 2026).

Basic Information

Owner and Executive Chairman, Los Angeles Times; founder, NantWorks; Executive Chairman, ImmunityBio

Company Details

NantWorks / ImmunityBio / Los Angeles Times

Biotechnology, Healthcare, Media